Inventor · disambiguated record
Yves Pommier
Also filed as: POMMIER YVES · POMMIER YVES GEORGES
18 granted patents·10 pending applications·109 citations·filing 1992–2022
92Inventor score
Top patents by PatentIndex Score
28 records- 0191US6291676B1Water-soluble derivatives of camptothecin/homocamptothecinUNIV KENTUCKY RES FOUND·Filed 2000·Granted Sep 18, 2001·48 cites·2 claims
- 0280US5622960ATopoisomerase II inhibitors and therapeutic uses thereforUS ARMY·Filed 1992·Granted Apr 22, 1997·18 cites·9 claims
- 0374US6825206B1Camptothecin compounds with a thioether groupRES TRIANGLE INST·Filed 2000·Granted Nov 30, 2004·6 cites·8 claims
- 0473US8716295B2Fluoroquinolone derivatives or sulfonamide moiety-containing compounds as inhibitors of tyrosyl-dnaphosphodiesterase (TDP1)POMMIER YVES·Filed 2011·Granted May 6, 2014·4 cites·11 claims
- 0572US10906914B2Furoquinolinediones as inhibitors of TDP2AN LINKUN·Filed 2016·Granted Feb 2, 2021·2 cites·17 claims
- 0666US5747520ATopoisomerase II inhibitors and therapeutic uses thereforUS ARMY·Filed 1995·Granted May 5, 1998·9 cites·7 claims
- 0764US5606060ATopoisomerase II inhibitors and therapeutic uses thereforUS ARMY·Filed 1995·Granted Feb 25, 1997·8 cites·7 claims
- 0861US7015212B1Thiazepine inhibitors of HIV-1 integraseUS HEALTH·Filed 2000·Granted Mar 21, 2006·2 cites·22 claims
- 0960US9676771B2Compounds for inhibiting drug-resistant strains of HIV-1 integraseUS HEALTH·Filed 2014·Granted Jun 13, 2017·0 cites·24 claims
- 1059US11999747B2Furoquinolinediones as inhibitors of TDP2THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2021·Granted Jun 4, 2024·0 cites·16 claims
- 1158US8278100B2Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disordersPOMMIER YVES·Filed 2009·Granted Oct 2, 2012·0 cites·8 claims
- 1258US2024307369A1Exo VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial InfectionUS HEALTH·Filed 2021·Application pending·0 cites
- 1357US2024002445A1Tyrosyl-lock peptidesUS HEALTH·Filed 2021·Application pending·0 cites
- 1455US2009298934A1Diamidine Inhibitors of TDP1US GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 1553US10208035B2Compounds for inhibiting drug-resistant strains of HIV-1 integraseUS HEALTH·Filed 2017·Granted Feb 19, 2019·0 cites·21 claims
- 1652US2014142137A1Hiv integrase inhibitorsNAT INST HEALTH·Filed 2013·Application pending·0 cites
- 1752US2010152301A1Treatment of Viral InfectionsUS GOV HEALTH & HUMAN SERV·Filed 2006·Application pending·0 cites
- 1851US2025011330A1Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) InhibitorsTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2022·Application pending·0 cites
- 1948US8865686B2Tetracycline compounds as tyrosyl-DNA phosphodiesterase I inhibitorsPOMMIER YVES·Filed 2008·Granted Oct 21, 2014·0 cites·8 claims
- 2047US6355785B1Guanosine-rich oligonucleotide integrase inhibitorsARONEX PHARMACEUTICALS INC·Filed 1999·Granted Mar 12, 2002·12 cites·9 claims
- 2146US2023219895A1Oxynitidine derivatives useful as inhibitors of topoisomerase ib (top1) and tyrosyl-dna phosphodiesterase 1 (tdp1)THE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2019·Application pending·0 cites
- 2243US2015218120A1Hiv integrase inhibitorsUNIV CALIFORNIA·Filed 2015·Application pending·0 cites
- 2339US8765802B2Kinase inhibitors, compositions thereof, and methods of use therewithSHOEMAKER ROBERT·Filed 2008·Granted Jul 1, 2014·0 cites·3 claims
- 2439US7776883B2Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)US HEALTH·Filed 2005·Granted Aug 17, 2010·0 cites·42 claims
- 2538US9278089B2Method of treating HCV infection with a small molecule CHK2 inhibitorUS OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICE·Filed 2012·Granted Mar 8, 2016·0 cites·23 claims
- 2638US8912214B2Use of Chk2 kinase inhibitors for cancer treatmentPOMMIER YVES·Filed 2006·Granted Dec 16, 2014·0 cites·20 claims
- 2738US2021220329A1A method of treating triple-negative breast cancerTHE UNITED STATE OF AMERICA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICE·Filed 2019·Application pending·0 cites
- 2837US2006063938A1Compounds to treat hiv infection and aidsBURKE TERRENCE R·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yves Pommier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →